Bernard Chatelain
Yvoir, WAL 5530, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Breaking Free From MCHC Interferences? French-Speaking Cellular Haematology Group (GFHC) Review of Causes, Rising Trends and Practical Solutions.
Journal: International journal of laboratory hematology
Published: March 08, 2025
Influence of Anticoagulants on Platelet Counts: A Study and Recommendations From the French Speaking Cellular Hematology Group (GFHC).
Journal: International journal of laboratory hematology
Published: August 05, 2024
Letter in response to Othman & Favaloro "Comparison of two ways of performing ristocetin-induced platelet agglutination (RIPA) mixing study for diagnosis of type 2B VWD".
Journal: Research and practice in thrombosis and haemostasis
Published: May 30, 2023
Perls' Stain Guidelines from the French-Speaking Cellular Hematology Group (GFHC).
Journal: Diagnostics (Basel, Switzerland)
Published: May 30, 2022
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system.
Journal: Thrombosis journal
Published: May 24, 2022
Pseudothrombocytopenia-A Review on Causes, Occurrence and Clinical Implications.
Journal: Journal of clinical medicine
Published: December 31, 2020
Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?
Journal: Annales de biologie clinique
Published: October 07, 2020
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory.
Journal: Thrombosis journal
Published: June 02, 2020
Effects of Time-Interval since Blood Draw and of Anticoagulation on Platelet Testing (Count, Indices and Impedance Aggregometry): A Systematic Study with Blood from Healthy Volunteers.
Journal: Journal of clinical medicine
Published: May 16, 2020
Clustering and Kernel Density Estimation for Assessment of Measurable Residual Disease by Flow Cytometry.
Journal: Diagnostics (Basel, Switzerland)
Published: March 26, 2020
Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia.
Journal: Leukemia
Published: February 25, 2020
Evaluation of a new thromboplastin reagent STA-NeoPTimal on a STA R Max analyzer for the measurement of prothrombin time, international normalized ratio and extrinsic factor levels.
Journal: International journal of laboratory hematology
Published: January 14, 2020
Last Updated: 09/26/2026